Skip to content

Effect of Kanchanar Guggulu and Varunadi Kashaya with and without Virechana in the Management of Hypothyroidism in Adolescents

Evaluation of Kanchanar Guggulu and Varunadi Kashaya with and without Virechana in the Management of Hypothyroidism in Adolescents- An Open-Label Randomized Controlled Comparative Clinical Trial

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/051020
Enrollment
150
Registered
2023-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals of either gender between the age group of 10 - 16 years. 2. Diagnosed cases/new cases of hypothyroidism on the basis of Sr. TSH, T3, and T4 levels. a. Subclinical hypothyroidism- 5-10µIU/ml with minimal or absence of symptoms b. Clinical hypothyroidism- > 5 µIU/ml with clinical symptoms 3. Parents giving consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Recent thyroid surgery or radioiodine therapy within 1-year of the studyâ??s start date. 2. History or presence of clinically relevant cardiovascular, renal, metabolic, hematological, neurological, psychiatric, systemic, or infectious disease or malignant tumor, hereditary diseases, or syndromes. 3. Severe mental disorder. 4. Recent hospitalization for a major illness or elective surgery within 1-year of the studyâ??s start date 5. Diabetes mellitus type-1 patients. 6. Patient/Parents not willing to participate in the study.

Design outcomes

Primary

MeasureTime frame
â?¢To assess the efficacy in reducing the level of TSH.Timepoint: 0th day, 15th day, 60th day and 120th day

Secondary

MeasureTime frame
â?¢ To assess the efficacy in the improvement of clinical features of Hypothyroidism. â?¢ To assess the efficacy in tapering the dose of levothyroxine. â?¢ To assess the efficacy in Zulewskis clinical score. Timepoint: 0th day, 60th day and 120th day

Countries

India

Contacts

Public ContactDr Mahapatra Arun kumar

All India Institute of Ayurveda

srajagopala@gmail.com7600902564

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026